Skip to search formSkip to main contentSkip to account menu

dihydrolenperone

Known as: 1-Butanone, 1-(4-fluorophenyl)-4-[4-[(4-fluorophenyl)hydroxymethyl]-1-piperidi nyl]-, 1-Butanone, 1-(4-fluorophenyl)-4-[4-[(4-fluorophenyl)hydroxymethyl]-1-piperidinyl]-, Dihydro-lenperone 
A butyrophenone that has been investigated for antineoplastic activity. (NCI04)
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Butyrophenones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
General pharmacological properties of the new proton pump inhibitor (+/-)-5-methoxy-2-[[(4-methoxy-3,5-dimethylpyrid-2-yl)methyl]sulf inyl]- 1H-imidazo[4,5-b]pyridine.
The general pharmacological profiles of a novel proton pump inhibitor, (+/-)-5-methoxy-2-[[(4-methoxy-3,5-dimethylpyrid-2-yl… 
1993
1993
Phase I trial of dihydrolenperone in lung cancer patients: A novel compound within vitro activity against lung cancer
SummaryAntitumor activity of the butyrophenone dihydrolenperone in non-small cell lung cancer was initially suggested byin vitro… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)